UB Paderborn / Katalog / Suche / in CDI

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

Journal of clinical oncology, 1998-02, Vol.16 (2), p.405-410

1998

Volltextzugriff (PDF)

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1736-1744

1999

Volltextzugriff (PDF)

Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2001-01, Vol.19 (2), p.364-367

2001

Volltextzugriff (PDF)

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study

Gynecologic oncology, 1999-02, Vol.72 (2), p.131-137

1999

Volltextzugriff (PDF)

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2101-2112

1996

Volltextzugriff (PDF)

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study

Gynecologic oncology, 2004-05, Vol.93 (2), p.336-339

2004

Volltextzugriff (PDF)

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1589-1599

1995

Volltextzugriff (PDF)

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

Journal of clinical oncology, 1991-07, Vol.9 (7), p.1138-1150

1991

Volltextzugriff (PDF)

Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study

International journal of gynecological cancer, 2004-03, Vol.14 (2), p.341-347

2004

Volltextzugriff (PDF)

A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology Group study

Gynecologic oncology, 2011-03, Vol.120, p.S2-S2

2011

Volltextzugriff (PDF)

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

Gynecologic oncology, 1991, Vol.40 (1), p.55-65

1991

Volltextzugriff (PDF)

Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2011-03, Vol.120, p.S5-S5

2011

Volltextzugriff (PDF)

Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment

Gynecologic oncology, 2010-03, Vol.116 (3), p.595-595

2010

Volltextzugriff (PDF)

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer: Results of Two Prospective Randomized Trials

The New England journal of medicine, 1990-04, Vol.322 (15), p.1021-1027

1990

Volltextzugriff (PDF)

An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic oncology, 1996-12, Vol.63 (3), p.304-311

1996

Volltextzugriff (PDF)

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

American journal of obstetrics and gynecology, 1994-04, Vol.170 (4), p.974-980

1994

Volltextzugriff (PDF)

Results of revision total knee arthroplasty after exposure of the knee with extensor mechanism tenolysis

The Journal of arthroplasty, 2004-09, Vol.19 (6), p.751-756

2004

Volltextzugriff (PDF)

Patient Characteristics and Outcomes for Locally Advanced Cervical Cancer in Minority and Underserved Populations in Eastern North Carolina

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S563-S563

2007

Volltextzugriff (PDF)

Prognostic Factors for Groin Node Metastasis in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study)

Gynecologic oncology, 1993-06, Vol.49 (3), p.279-283

1993

Volltextzugriff (PDF)

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

Gynecologic oncology, 1999-02, Vol.72 (2), p.148-153

1999

Volltextzugriff (PDF)

Management of endometrial cancer

American journal of obstetrics and gynecology, 1996-02, Vol.174 (2), p.529-534

Homesley, Howard D.

1996

Volltextzugriff (PDF)

Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study

American journal of obstetrics and gynecology, 1998-01, Vol.178 (1 Pt 1), p.62-65

1998

Volltextzugriff (PDF)

Management of vulvar cancer

Cancer, 1995-11, Vol.76 (S10), p.2159-2170

Homesley, Howard D.

1995

Volltextzugriff (PDF)

Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes

Obstetrics and gynecology (New York. 1953), 1986-12, Vol.68 (6), p.733-740

1986

Volltextzugriff (PDF)

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

Gynecologic oncology, 2002-11, Vol.87 (2), p.171-177

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study

A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology Group study

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study

Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer: Results of Two Prospective Randomized Trials

An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group Study

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Results of revision total knee arthroplasty after exposure of the knee with extensor mechanism tenolysis

Patient Characteristics and Outcomes for Locally Advanced Cervical Cancer in Minority and Underserved Populations in Eastern North Carolina

Prognostic Factors for Groin Node Metastasis in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study)

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

Management of endometrial cancer

Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study

Management of vulvar cancer

Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

Suchergebnisse filtern